What we think and what we know

被引：5

作者：

Buse, J

Raftery, L

机构：

[1] Univ N Carolina, Sch Med & UNC Hlth Care, Div Endocrinol, Chapel Hill, NC 27599 USA

[2] Univ N Carolina, Sch Med & UNC Hlth Care, Div Gen Med & Clin Epidemiol, Chapel Hill, NC 27599 USA

来源：

DIABETES CARE | 2002年 / 25卷 / 10期

关键词：

D O I：

10.2337/diacare.25.10.1876

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1876 / 1878

页数：3

共 7 条

[1] Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial [J].

Barrett-Connor, E ;

Grady, D ;

Sashegyi, A ;

Anderson, PW ;

Cox, DA ;

Hoszowski, K ;

Rautaharju, P ;

Harper, KD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07) :847-857

[2] Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women [J].

Crespo, CJ ;

Smit, E ;

Snelling, A ;

Sempos, CT ;

Andersen, RE .

DIABETES CARE, 2002, 25 (10) :1675-1680

[3] Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].

Cummings, SR ;

Black, DM ;

Thompson, DE ;

Applegate, WB ;

Barrett-Connor, E ;

Musliner, TA ;

Palermo, L ;

Prineas, R ;

Rubin, SM ;

Scott, JC ;

Vogt, T ;

Wallace, R ;

Yates, AJ ;

LaCroix, AZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082

[4] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].

Ettinger, B ;

Black, DM ;

Mitlak, BH ;

Knickerbocker, RK ;

Nickelsen, T ;

Genant, HK ;

Christiansen, C ;

Delmas, PD ;

Zanchetta, JR ;

Stakkestad, J ;

Glüer, CC ;

Krueger, K ;

Cohen, FJ ;

Eckert, S ;

Ensrud, KE ;

Avioli, LV ;

Lips, P ;

Cummings, SR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645

[5] Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study - Lessons learned [J].

Furberg, CD ;

Vittinghoff, E ;

Davidson, M ;

Herrington, DM ;

Simon, JA ;

Wenger, NK ;

Hulley, S .

CIRCULATION, 2002, 105 (08) :917-922

[6] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].

Hulley, S ;

Grady, D ;

Bush, T ;

Furberg, C ;

Herrington, D ;

Riggs, B ;

Vittinghoff, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613

[7] Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial [J].

Rossouw, JE ;

Anderson, GL ;

Prentice, RL ;

LaCroix, AZ ;

Kooperberg, C ;

Stefanick, ML ;

Jackson, RD ;

Beresford, SAA ;

Howard, BV ;

Johnson, KC ;

Kotchen, JM ;

Ockene, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :321-333

← 1 →